| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |